On Thursday, Tilray Inc (NASDAQ: TLRY) announced its GMP-certified medical cannabis oral solution has reached Ireland. In this manner, Ireland became the 13th country where Tilray’s products are imported, as the company works on its global expansion in Europe.
At the end of June, the Department of Health in Ireland approved the Medical Cannabis Access Programme that enables patients in need of medical cannabis to obtain it. Through this program, Tilray oral solutions should reach qualified patients in Ireland during the second half of the year.
Benzinga's Cannabis Capital Conference heads to Detroit on Aug. 15 -- Click here to learn more!
“This development in Ireland represents an exciting turning point for patients,” said Cahterine Jacobson, Tilray’s Vice President of Medical and Regulatory Affairs. “We’re proud to have the opportunity to provide patients in Ireland with access to Tilray’s standardized GMP-certified medical cannabis products, and we’re thrilled to see an increasing number of countries improve access to medical cannabis. We will continue to do our part to increase access for patients in need around the world."
Tilray's shares traded around $43.48 at time of publication.
Never miss a news story in the cannabis world. Click here to check out Benzinga Cannabis for more.
See more from Benzinga
- Cannabis Real Estate Firm BANGI Receives Michigan Hemp Production License
- Mysteriously Planted Cannabis Discovered On Vermont State House Grounds
- Cannabis One Holdings To Acquire Green Lady, Expand To Pacific Northwest
© 2019 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.